- 专利标题: Tissue-engineered constructs
-
申请号: US14495310申请日: 2014-09-24
-
公开(公告)号: US09650603B2公开(公告)日: 2017-05-16
- 发明人: Shannon L. M. Dahl , Laura E. Niklason , Justin T. Strader , William E. Tente , Joseph J. Lundquist
- 申请人: Humacyte, Inc.
- 申请人地址: US NC Morrisville
- 专利权人: Humacyte, Inc.
- 当前专利权人: Humacyte, Inc.
- 当前专利权人地址: US NC Morrisville
- 代理机构: Cooley LLP
- 代理商 Ivor R. Elrifi
- 主分类号: A61F2/06
- IPC分类号: A61F2/06 ; C12N5/00 ; A61F2/04 ; B29C53/00 ; B29C53/36 ; A61L27/34 ; B29K67/00 ; B29K105/00 ; B29L23/00 ; B29L31/00
摘要:
The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
公开/授权文献
- US20150031131A1 TISSUE-ENGINEERED CONSTRUCTS 公开/授权日:2015-01-29
信息查询
IPC分类: